Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia (IPPOEM)
Esophageal Achalasia
About this trial
This is an interventional treatment trial for Esophageal Achalasia
Eligibility Criteria
Inclusion Criteria: Patient with an indication for esophageal POEM for achalasia Patient with all types of achalasia with Eckardt score > 3 The patient must have given their free and informed consent and signed the consent form The patient must be a member or beneficiary of a health insurance plan Exclusion Criteria: Patient with contraindications to PPIs Patient with mediastinal and esophageal neoplasia Patient with a history of Heller myotomy surgery Patients requiring any type of anti-reflux valve surgery The subject is in a period of exclusion determined by a previous study It is impossible to give the subject informed information The patient is under safeguard of justice or state guardianship Patient is pregnant, parturient or breastfeeding
Sites / Locations
- AP-HMRecruiting
- CHU de MontpellierRecruiting
- Clinique mutualiste BeausoleilRecruiting
- CHU de NîmesRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Systematic protein pump inhibitor therapy
Protein pump inhibitor therapy as necessary